Illumina Posts 66 Percent Revenue, Profit Gain in Q2; Acquires Sequencing Startup | GenomeWeb
This article has been updated to include comments from a conference call and a stock quote.
 
NEW YORK (GenomeWeb News) – Illumina reported after the close of the market on Tuesday that its second-quarter revenues and profit each increased 66 percent year over year. The firm also said that it has acquired Avantome, a privately held developer of low-cost, long read-length sequencing technology.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.